Skip to search formSkip to main contentSkip to account menu

cryptophycin

Known as: 10-((3-Chloro-4-methoxyphenyl)methyl)-6-methyl-3-(2-methylpropyl)-16-(1-(3-phenyloxiranyl)ethyl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone 
The cryptophycins are a family of 16-membered macrolide antimitotic agents isolated from the cyanobacteria Nostoc sp. The mechanism of anticancer… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Two analogues of cryptophycin were synthesized and biologically evaluated for their in‐vitro cytotoxicities against several solid… 
2006
2006
A hybrid structure was synthesized in which one portion is characteristic of a cryptophycin and a second sector bears the… 
2004
2004
Tubulin with bound [5-3H]dolastatin 10 was exposed to ultraviolet light, and 8–10% of the bound drug cross-linked to the protein… 
2003
2003
Fluorescence correlation spectroscopy (FCS) was applied to investigate the stability of tubulin rings that result from the… 
2003
2003
A novel, efficient, and stereoselective synthesis of fragment A of cryptophycin 3 is disclosed. The key step involves the regio… 
2002
2002
The cryptophycin analogue LY355703 is a potent inhibitor of microtubule polymerization that displays in vitro and in vivo… 
2001
2001
[see structure]. An efficient, concise approach to the macrolide core of the cryptophycins, potent antimitotic agents, has been… 
2000
2000
[structure--see text] An efficient and highly stereoselective synthesis of cryptophycin B (2), a potent cytotoxic agent, is… 
1999
1999
The synthesis of unit A of the cryptophycins from (S)-trans-3-penten-2-ol and from (S)-trans-4-hexen-3-ol has been completed. The…